CCL8



CCL8

E1EE1K2KK2L3LL3T4TT4G5GG5P6PP6D7DD7K8KK8A9AA9P10PP10V11VV11T12TT12C13CC13C14CC14F15FF15H16HH16V17VV17L18LL18K19KK19L20LL20K21KK21I22II22P23PP23L24LL24R25RR25V26VV26L27LL27K28KK28S29SS29Y30YY30E31EE31R32RR32I33II33N34NN34N35NN35I36II36Q37QQ37C38CC38P39PP39M40MM40E41EE41A42AA42V43VV43V44VV44F45FF45Q46QQ46T47TT47... and 31 more residue(s)...... and 31 more residue(s)

SMILES None
InChIKey None
Sequence EKLTGPDKAPVTCCFHVLKLKIPLRVLKSYERINNIQCPMEAVVFQTKQGMSLCVDPTQKWVSEYMEILDQKSQILQP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL8

E1EE1K2KK2L3LL3T4TT4G5GG5P6PP6D7DD7K8KK8A9AA9P10PP10V11VV11T12TT12C13CC13C14CC14F15FF15H16HH16V17VV17L18LL18K19KK19L20LL20K21KK21I22II22P23PP23L24LL24R25RR25V26VV26L27LL27K28KK28S29SS29Y30YY30E31EE31R32RR32I33II33N34NN34N35NN35I36II36Q37QQ37C38CC38P39PP39M40MM40E41EE41A42AA42V43VV43V44VV44F45FF45Q46QQ46T47TT47... and 31 more residue(s)...... and 31 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.